Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 61 Records) |
Query Trace: Colorectal Neoplasms and meta-analysis and KRAS[original query] |
---|
Germline polymorphisms as biomarkers of tumor response in colorectal cancer patients treated with anti-EGFR monoclonal antibodies: a systematic review and meta-analysis. The pharmacogenomics journal 2016 Nov . Morgen E K, Lenz H-J, Jonker D J, Tu D, Milano G, Graziano F, Zalcberg J, Karapetis C S, Dobrovic A, O'Callaghan C J, Liu |
The impact of primary tumor location on efficacy of cetuximab in metastatic colorectal cancer patients with different Kras status: a systematic review and meta-analysis. Oncotarget 2017 (32): 53631-53641. Cao De-Dong, Xu Hui-Lin, Xu Xi-Ming, Ge W |
Prognostic value of KRAS codon 13 gene mutation for overall survival in colorectal cancer: Direct and indirect comparison meta-analysis. Medicine 2017 Sep 96 (35): e7882. Kwak Min Seob, Cha Jae Myung, Yoon Jin Young, Jeon Jung Won, Shin Hyun Phil, Chang Hye Jung, Kim Hyung Kyung, Joo Kwang Ro, Lee Joung |
Cell-Free DNA in Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis. The oncologist 2017 Aug . Spindler Karen-Lise G, Boysen Anders K, Pallisgård Niels, Johansen Julia S, Tabernero Josep, Sørensen Morten M, Jensen Benny V, Hansen Torben F, Sefrioui David, Andersen Rikke F, Brandslund Ivan, Jakobsen Ande |
The prognostic value of KRAS mutation by cell-free DNA in cancer patients: A systematic review and meta-analysis. PloS one 2017 12 (8): e0182562. Zhuang Rongyuan, Li Song, Li Qian, Guo Xi, Shen Feng, Sun Hong, Liu Tians |
Retraction: Evaluation and identification of factors related to KRAS and BRAF gene mutations in colorectal cancer: A meta analysis. Journal of cancer research and therapeutics 0 13 (1): 156. Authors are not available |
Effectiveness of circulating tumor DNA for detection of KRAS gene mutations in colorectal cancer patients: a meta-analysis. OncoTargets and therapy 2017 10 945-953. Hao Yi-Xin, Fu Qiang, Guo Yan-Yan, Ye Ming, Zhao Hui-Xia, Wang Qi, Peng Xiu-Mei, Li Qiu-Wen, Wang Ru-Liang, Xiao Wen-H |
Evaluation and identification of factors related to KRAS and BRAF gene mutations in colorectal cancer: A meta-analysis. Journal of cancer research and therapeutics 2016 Dec 12 (Supplement): C191-C198. Lin Li, Chen Guang-Yong, Xu Chun-Wei, Wang Hai-Yan, Wu Yong-Fang, Fang Mei- |
Increased Frequency of KRAS Mutations in African Americans Compared with Caucasians in Sporadic Colorectal Cancer. Clinical and translational gastroenterology 2017 Oct 8 (10): e124. Staudacher Jonas J, Yazici Cemal, Bul Vadim, Zeidan Joseph, Khalid Ahmer, Xia Yinglin, Krett Nancy, Jung Barba |
KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: a meta-analysis. Oncotarget 2017 Jan . Du Lijun, Kim John J, Shen Jinhua, Chen Binrui, Dai Ni |
Efficacy and safety of TAS-102 in refractory metastatic colorectal cancer: a meta-analysis. Cancer management and research 2018 10 2915-2924. Chen Duke, Wu Yu-Shen, Lin Huapeng, Wang Yihan, Li Longhao, Zhang T |
Clinical, Pathological, and Molecular Characteristics of CpG Island Methylator Phenotype in Colorectal Cancer: A Systematic Review and Meta-analysis. Translational oncology 2018 8 11 (5): 1188-1201. Advani Shailesh M, Advani Pragati, DeSantis Stacia M, Brown Derek, VonVille Helena M, Lam Michael, Loree Jonathan M, Mehrvarz Sarshekeh Amir, Bressler Jan, Lopez David S, Daniel Carrie R, Swartz Michael D, Kopetz Sco |
Mutations of key driver genes in colorectal cancer progression and metastasis. Cancer metastasis reviews 2018 Jan . Huang Dongdong, Sun Wenjie, Zhou Yuwei, Li Peiwei, Chen Fang, Chen Hanwen, Xia Dajing, Xu Enping, Lai Maode, Wu Yihua, Zhang Hong |
PIK3CA mutation and clinicopathological features of colorectal cancer: a systematic review and Meta-Analysis. Acta oncologica (Stockholm, Sweden) 2019 9 59 (1): 66-74. Jin Juan, Shi Yaqin, Zhang Shu, Yang Shuof |
The incidence of infusion reactions associated with monoclonal antibody drugs targeting the epidermal growth factor receptor in metastatic colorectal cancer patients: A systematic literature review and meta-analysis of patient and study characteristics. Cancer medicine 2019 Aug . Bylsma Lauren C, Dean Rebecca, Lowe Kimberly, Sangaré Laura, Alexander Dominik D, Fryzek Jon |
Impact of primary colorectal Cancer location on the KRAS status and its prognostic value. BMC gastroenterology 2019 Mar 19 (1): 46. Xie Ming-Zhi, Li Ji-Lin, Cai Zheng-Min, Li Ke-Zhi, Hu Bang- |
Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: A systematic review and meta-analysis. Cancer medicine 2019 Dec . Bylsma Lauren C, Gillezeau Christina, Garawin Tamer A, Kelsh Michael A, Fryzek Jon P, Sangaré Laura, Lowe Kimberly |
Impact of KRAS mutation status on outcomes of metastatic colorectal cancer treated with anti-angiogenic agents: a meta-analysis. Journal of chemotherapy (Florence, Italy) 2019 Dec 1-8. Liang Xiaojun, Shen J |
The diagnostic accuracy of digital PCR, ARMS and NGS for detecting KRAS mutation in cell-free DNA of patients with colorectal cancer: A protocol for systematic review and meta-analysis. Medicine 2020 6 99 (26): e20708. Ye Peng, Cai Peiling, Xie Jing, Wei Yuanyu |
Comparison of efficacy and safety for patients with beyond second line treated metastatic colorectal cancer: a network meta-analysis of randomized controlled trials. Journal of chemotherapy (Florence, Italy) 2020 2 32 (4): 163-170. Cao Meihui, Zhou Mingyi, Zhang Jingdo |
A Systematic Literature Review and Meta-Analysis Describing the Prevalence of KRAS, NRAS, and BRAF Gene Mutations in Metastatic Colorectal Cancer. Gastroenterology research 2020 11 13 (5): 184-198. Levin-Sparenberg Elizabeth, Bylsma Lauren C, Lowe Kimberly, Sangare Laura, Fryzek Jon P, Alexander Dominik |
Signal transduction pathway mutations in gastrointestinal (GI) cancers: a systematic review and meta-analysis. Scientific reports 2020 10 10 (1): 18713. Tabibzadeh Alireza, Tameshkel Fahimeh Safarnezhad, Moradi Yousef, Soltani Saber, Moradi-Lakeh Maziar, Ashrafi G Hossein, Motamed Nima, Zamani Farhad, Motevalian Seyed Abbas, Panahi Mahshid, Esghaei Maryam, Ajdarkosh Hossein, Mousavi-Jarrahi Alireza, Niya Mohammad Hadi Karbala |
Reevaluating the prognostic role of BRAF mutation in colorectal cancer liver metastases. American journal of surgery 2021 Sep . Pikouli Anastasia, Papaconstantinou Dimitrios, Wang Jane, Kavezou Foteini, Pararas Nikolaos, Nastos Constantinos, Pikoulis Emmanouil, Margonis Georgios Antoni |
KRAS and BRAF mutations in Iranian colorectal cancer patients: A systematic review and meta-analysis. Caspian journal of internal medicine 2020 11 (4): 355-369. Yari Abolfazl, Afzali Asiyeh, Aalipour Mostafa, Nakheai Mehran, Zahedi Mohammad Jav |
Systematic review of tumour budding and association with common mutations in patients with colorectal cancer. Critical reviews in oncology/hematology 2021 Oct 167 103490. Hatthakarnkul Phimmada, Quinn Jean A, Matly Amna Ahmed Mohemmd, Ammar Aula, van Wyk Hester C, McMillan Donald C, Edwards Joan |
The Molecular Associations of Signet-Ring Cell Carcinoma in Colorectum: Meta-Analysis and System Review. Medicina (Kaunas, Lithuania) 2022 7 58 (7): . Liu Xueting, Huang Litao, Liu Menghan, Wang Z |
Prognostic and Predictive Value of PIK3CA Mutations in Metastatic Colorectal Cancer. Targeted oncology 2022 Jun . Tan Elaine S, Fan Wenyi, Knepper Todd C, Schell Michael J, Sahin Ibrahim H, Fleming Jason B, Xie H |
Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis. ESMO open 2022 Jun 7 (3): 100511. Yoshino T, Van Cutsem E, Li J, Shen L, Kim T W, Sriuranpong V, Xuereb L, Aubel P, Fougeray R, Cattan V, Amellal N, Ohtsu A, Mayer R |
Does RAS Status Increase the Prevalence of Positive Resection Margin in Colorectal Liver Metastasis? A Systematic Review and Meta-Analysis. The American surgeon 2023 3 31348231156763. Brandão Gabriela Rangel, Trindade Bruna Oliveira, Flores Luís Henrique Fernandes, Motter Sarah Bueno, Alves Cassio Bona, Remonti Tiago Auatt Paes, Lucchese Angélica Maria, Junior Antonio Dal Pizzol, Kalil Antonio Nocc |
Prognostic and predictive biomarkers for anti-EGFR monoclonal antibody therapy in RAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis. BMC cancer 2023 11 23 (1): 1117. Xiaona Lu, Yuyao Li, Yue Li, Xuemei Zhang, Jia Shi, Hai Feng, Zhuo Yu, Yueqiu G |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 29, 2024
- Content source: